4//SEC Filing
MANZO MICHAEL P. 4
Accession 0001104659-20-022843
CIK 0001372514other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:31 PM ET
Size
7.5 KB
Accession
0001104659-20-022843
Insider Transaction Report
Form 4
MANZO MICHAEL P.
Vice President of Engineering
Transactions
- Award
Common Stock
2020-02-14+7,500→ 18,421 total - Award
Stock Option (right to buy)
2020-02-14+7,500→ 7,500 totalExercise: $6.55Exp: 2030-02-14→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on February 1, 2021, and the remaining balance will vest monthly on the first day of each calendar month thereafter for a period of two years.
- [F2]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2021, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001620189
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:31 PM ET
- Size
- 7.5 KB